Clinical Trial: A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088913) titled 'A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants' on July 17.

Brief Summary: The purpose of the study is to assess the effect of capivasertib on the pharmacokinetics (PK) of oral rosuvastatin in healthy participants.

Study Start Date: July 28

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Capivasertib

Capivasertib will be administered orally twice in Period 2.

DRUG: Rosuvastatin

Rosuvastatin will be administered orally once in both Period 1 and Period 2.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Publish...